Alpha-Galactosidase Microplate Assay Kit

Background/Introduction: Albumin-to-Creatinine Ratio (ACR) is one of the two markers used to determine chronic kidney disease (CKD). ACR is recommended to be measured on regular basis on people living with Type I and Type II diabetes. ACR is defined as the ratio between albumin (reported in mg/dl) and creatinine (reported in g/dl). This ratio estimates the amount of albumin excreted in urine during a 24 hr period. Albuminuria is identified when ACR is greater than 30 mg albumin/g creatinine. ACR Assay Kit provides a simple, sensitive, and highthroughput adaptable assay that detects albumin (detection range: 0.02-2.5 mg/ml), creatinine (detection range: 0.002-0.5 mg/ml) and Albumin-to-creatinine ratio. The ACR ratio is determined in two steps: First, albumin is determined by using a probe (AB580) that specifically recognizes albumin (Ex/Em = 600/630 nm). Second, creatinine is converted to sarcosine via enzymatic reactions. Sarcosine is specifically oxidized generating a product that reacts with a probe producing a chromophore that can be detected at 570 nm.

Small volumes of SCO0284 assay kit vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS8243211 is an assay kit targeting SCO0284. Also known as Alpha-Galactosidase Microplate Assay Kit. Reactive in General.